TCM
Tang Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.17M | Hold |
800,000
| – | – | 0.36% | 68 |
|
|
2025
Q1 | $6M | Hold |
800,000
| – | – | 0.33% | 69 |
|
|
2024
Q4 | $6.02M | Hold |
800,000
| – | – | 0.4% | 63 |
|
|
2024
Q3 | $6.08M | Hold |
800,000
| – | – | 0.43% | 64 |
|
|
2024
Q2 | $4.94M | Hold |
800,000
| – | – | 0.5% | 58 |
|
|
2024
Q1 | $4.06M | Hold |
800,000
| – | – | 0.42% | 64 |
|
|
2023
Q4 | $4.79M | Sell |
800,000
-1,000,000
| -56% | -$5.99M | 0.44% | 59 |
|
|
2023
Q3 | $12.7M | Sell |
1,800,000
-650,000
| -27% | -$4.6M | 1.8% | 16 |
|
|
2023
Q2 | $17.2M | Buy |
2,450,000
+850,000
| +53% | +$5.98M | 2.54% | 12 |
|
|
2023
Q1 | $13.3M | Buy |
1,600,000
+150,000
| +10% | +$1.25M | 1.99% | 16 |
|
|
2022
Q4 | $16.6M | Buy |
1,450,000
+250,000
| +21% | +$2.87M | 2.42% | 13 |
|
|
2022
Q3 | $15.1M | Hold |
1,200,000
| – | – | 1.85% | 17 |
|
|
2022
Q2 | $12.7M | Buy |
+1,200,000
| New | +$12.7M | 1.93% | 18 |
|
|
2016
Q3 | – | Sell |
-430,000
| Closed | -$1.22M | – | 9 |
|
|
2016
Q2 | $1.22M | Hold |
430,000
| – | – | 0.54% | 9 |
|
|
2016
Q1 | $1.22M | Buy |
+430,000
| New | +$1.22M | 0.55% | 11 |
|